In vivo animal model evaluation of a powerful oral nanomedicine for treating breast cancer in balb/c mice using 4t1 cell lines without chemotherapy

HIGHLIGHTS

• who: Zahra Fakhroueian and collaborators from the School of Chemical Engineering (Nanomedicine), College of Engineering, University of Tehran, Tehran, Iran have published the paper: In Vivo Animal Model Evaluation of a Powerful Oral Nanomedicine for Treating Breast Cancer in BALB/c Mice Using 4T1 Cell Lines without Chemotherapy, in the Journal: (JOURNAL)
• what: This research has been done in animal labs as Balb/c mice in ZFP (Zist Faravard Pars, Tehran, Iran) company based on moral code (ethical principles). Groups Blood parameters Nanoparticle concentration (µg/ml) Lymphocyte (%) Neutrophil (%) Monocyte (%) Intraperitoneal nanodrug receiver Injector nanodrug receiver . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.